BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28653903)

  • 21. LncRNA AK023948 is a positive regulator of AKT.
    Koirala P; Huang J; Ho TT; Wu F; Ding X; Mo YY
    Nat Commun; 2017 Feb; 8():14422. PubMed ID: 28176758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.
    Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW
    Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
    Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
    Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Li JY; Ma X; Zhang CB
    Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
    Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
    BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
    Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
    Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of CCT137690 on long non-coding RNA expression profiles in MCF-7 and MDA-MB-231 cell lines.
    Balcı Okcanoğlu T; Kayabaşı Ç; Gündüz C
    Bosn J Basic Med Sci; 2020 Feb; 20(1):56-62. PubMed ID: 31319040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.
    Rahmatpanah FB; Jia Z; Chen X; Char JE; Men B; Franke AC; Jones FE; McClelland M; Mercola D
    Oncotarget; 2015 Jan; 6(2):1286-301. PubMed ID: 25428913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
    Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
    Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration.
    Cao Y; Lin M; Bu Y; Ling H; He Y; Huang C; Shen Y; Song B; Cao D
    Int J Oncol; 2017 May; 50(5):1671-1682. PubMed ID: 28339031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
    Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
    BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
    Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
    Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
    Shang C; Guo Y; Zhang J; Huang B
    Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA CRALA is associated with poor response to chemotherapy in primary breast cancer.
    Li Y; Wang B; Lai H; Li S; You Q; Fang Y; Li Q; Liu Y
    Thorac Cancer; 2017 Nov; 8(6):582-591. PubMed ID: 28834648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.
    Jiao C; Song Z; Chen J; Zhong J; Cai W; Tian S; Chen S; Yi Y; Xiao Y
    Oncol Rep; 2016 Nov; 36(5):2960-2966. PubMed ID: 27667646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
    Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.